Literature DB >> 26823348

Black bone disease in a healing fracture.

Desmond Thiam1, Tse Yean Teo1, Rishi Malhotra1, Kong Bing Tan2, Yu Han Chee1.   

Abstract

Black bone disease refers to the hyperpigmentation of bone secondary to prolonged usage of minocycline. We present a report of a 34-year-old man who underwent femoral shaft fracture fixation complicated by deep infection requiring debridement. The implants were removed 10 months later after long-term treatment with minocycline and fracture union. A refracture of the femoral shaft occurred 2 days after implant removal and repeat fixation was required. Intraoperatively, abundant heavily pigmented and dark brown bone callus was noted over the old fracture site. There was no evidence of other bony pathology and the appearance was consistent with minocycline-associated pigmentation. As far as we are aware, this is the first case of black bone disease affecting callus within the interval period of bone healing. We also discuss the relevant literature on black bone disease to bring light on this rare entity that is an unwelcomed surprise to operating orthopaedic surgeons. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26823348      PMCID: PMC4735432          DOI: 10.1136/bcr-2015-211915

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  31 in total

1.  Minocycline-induced blue-green discoloration of bone. A case report.

Authors:  Patrick E McCleskey; Kamala H Littleton
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

2.  Minocycline-induced black bone disease.

Authors:  Matthew J Hepburn; David P Dooley; Roman A Hayda
Journal:  Orthopedics       Date:  2005-05       Impact factor: 1.390

Review 3.  Minocycline and oral pigmentation.

Authors:  J M Cockings; N W Savage
Journal:  Aust Dent J       Date:  1998-02       Impact factor: 2.291

4.  Black bones: minocycline-induced bone pigmentation.

Authors:  Vishnusai Chauhan; Catherine McDougall
Journal:  Med J Aust       Date:  2014-07-21       Impact factor: 7.738

5.  Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells.

Authors:  Pedro Sousa Gomes; Maria Helena Fernandes
Journal:  Arch Oral Biol       Date:  2006-12-01       Impact factor: 2.633

6.  Black pigmentation of bone due to long-term minocycline use.

Authors:  S Pandit; W Hadden
Journal:  Surgeon       Date:  2004-08       Impact factor: 2.392

7.  Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.

Authors:  S G Holmes; K Still; D J Buttle; N J Bishop; P S Grabowski
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

8.  Removal of intramedullary rods after femoral shaft fracture.

Authors:  R Miller; S E Renwick; T A DeCoster; P Shonnard; F Jabczenski
Journal:  J Orthop Trauma       Date:  1992       Impact factor: 2.512

Review 9.  Minocycline-induced pigmentation. Incidence, prevention and management.

Authors:  D Eisen; M D Hakim
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

10.  Minocycline-induced black bone disease encountered during total knee arthroplasty.

Authors:  Dale N Reed; Frederick O Gregg; R Scott Corpe
Journal:  Orthopedics       Date:  2012-05       Impact factor: 1.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.